INTRODUCTION
Prevalence estimates of childhood hearing loss are expected to differ between countries primarily due to environmental factors such as the presence of endemic or epidemic diseases and differences in the level of medical care. Several large studies evaluating children ranging in age from 0 to 6 years and choosing the hearing thresholds >50-60 dB bilaterally, give different prevalence values of hearing impairment : Feinmesser M. et al., 1982 (Israel) . Therefore, the hearing impaired children need to be diagnosed and rehabilitated at the earliest for their proper development of speech, language and cognitive abilities (Joint Committee on Infant Hearing, National Institute of Health, 1991) 7 .
Brainstem Evoked Response Audiometry (BERA) has been established as the most reliable screening tool for hearing assessment in neonates since its first use in 1978 for this purpose. However, technical expertise required and time consumed in performing BERA in a neonate or a child makes this modality fall short of being an ideal screening tool. Transient Evoked Otoacoustic Emissions (TEOAE), a relatively newer modality for neonatal hearing screening, is a non-invasive test that can be performed in a newborn nursery, with little expertise required and in a shorter time as compared to BERA. The ever-growing number of candidates for hearing screening, especially in a country with very high birth rate like India generate a need for a screening modality for hearing assessment, which is reliable but at the same time requires less time and expertise. Present study was mainly designed to evaluate TEOAE as screening modality for hearing impairment and to compare it with BERA.
MATERIALS AND METHODS
The study was conducted between January 1, 2000 to April 15, 2002 in Lady Hardinge Medical College and associated Kalawati Saran Children's Hospital & Smt. Sucheta Kriplani Hospital, New Delhi.
SUBJECTS:
The study group constituted of 400 ears of 200 neonates (0-28 days) that were randomly selected without applying any highrisk criterion. The neonates were taken from Immunisation Clinic, Newborn Nursery, Neonatal ward and Intensive Care unit of our hospital. An informed consent for both the tests i.e. BERA and TEOAE were taken from one of the parents after explaining them the methods of testing in their own language.
METHODS:
Both TEOAE and BERA were performed in both the ears of all selected neonates (i.e. total 400 ears). The tests were carried out in quiet surroundings in the presence of their mothers, whenever possible. No special sound treatment of the room was done. The mother was instructed to feed the baby just prior to the testing. Most of the neonates fell asleep after getting their feed. The neonates who did not sleep after the feed were sedated using syrup Triclofos (25-30 mg / kg). TEOAE recordings were obtained on ILOV5 System (Otodynamics Ltd. UK) using SNS TEOAE probe with a removable soft tip. The size of the probe tip was selected after visually inspecting the neonate's ear canal size, so that a snug fit of TEOAE probe is achieved. Quick-Screen TEOAE stimulus was used for recording the emissions. The stimulus was in the form of clicks.
The clicks were 80 milliseconds (msec) in duration, with 12.5 msec. interval between two clicks and all presented at 80 dB SPL for the first three clicks of four stimulus sets, with a fourth non linear balancing click of opposite polarity that is three times the amplitude of the first three. The criteria used for passing a neonate on TEOAE were (i) Reproducibility of at least 50% or ii) Response Spectrum contained 3 dB more power than the noise spectrum in three of the frequencies (1.0, 1.5, 2.0, 3.0, 4.0 kHz). BERA was recorded using Neuro-otometrie Octavus System (Hortmann, Germany) giving 2000 broadband clicks in the rarefaction phase at the rate of 30clicks/sec. Presence of wave V at 60 dB was used as the passing criteria for BERA in these neonates. The time taken to complete TEOAE and BERA for every subject was recorded using a stopwatch. Figure 1 shows clearly the division of 400 ears into four groups depending upon the test results and the further detailed study outline (Fig. 1) .
RESULTS

Group I (True Negatives)
True Negatives for this study were defined as the ears that passed on TEOAE as well as BERA. Total of 344 ears fell in this group that was discharged from the study (Table 1) .
Group II (False Positives)
False Positives of this study were the ears that failed in TEOAE but passed on BERA. There were 48 ears (12.0%) with such results (Table 1 ). All these ears were subjected to otoscopy/ otoendoscopy. 31 ears had blocked External auditory canals (EACs) due to vernix/ debris, 4 ears with collapsible EACs and rest were normal. The repeat recordings were taken after suction cleaning of blocked EACs and with using long tipped probe. 16 out of 31 ears with blocked EACs and all 4 ears with collapsible EACs passed in this repeat TEOAE testing. The repeat failures were subjected to pneumatic otoscopy to see the status of tympanic membrane (TM) mobility. All except two ears showed normal or partial mobility of TM. These two ears were subjected to Impedance Audiometry and found to be having normal compliance and middle ear pressure.
Group III (True Positives)
True positives were the ears that failed on TEOAE as well as BERA. One neonate had bilateral and two had unilateral such outcomes i.e. 4 ears ( Table 1) . Otoscopy revealed no abnormality in these ears. These neonates were followed up for next 6 months. One neonate with unilateral failure was lost to the follow up. Rest 3 ears were subjected to repeat tests but they again failed in both tests.
Group IV (False Negatives) False Negatives for this study were the ears that passed on TEOAE but failed on BERA. There were 4 ears with such results (Table 1) . One premature neonate had bilateral and two neonates with congenital hyperbilirubinemia had unilateral absent BERA waveforms with normal TEOAE recordings. These neonates were followed up. The premature neonate passed in both BERA and TEOAE when this was repeated after the completion of gestational age. Other two neonates with congenital hyperbilirubinemia were subjected to repeat BERA and TEOAE after 6 months of follow up. One of them passed on BERA and TEOAE but the other still failed on BERA.
DISCUSSION
Pass Rate of TEOAE and BERA Pass rate of TEOAE calculated after first testing in all 400 ears was 87.0%. After otoscopy and suction cleaning, 20 more ears from group II passed on repeat TEOAE (i.e. turned True Negative from False positive). Thus, pass rate of TEOAE, increased from 87.0% to 92.0%. Pass rate of BERA calculated after first testing in all 400 ears was 98.0%. After completion of gestational age in premature neonates or six months of follow up, 3 more ears from group IV passed on repeat BERA (i.e. turned True Negative from False Negative). Thus, Pass rate of BERA increased from 98.0% to 98.75%.
Sensitivity and Specificity of TEOAE :
In the present study, sensitivity of TEOAE calculated using BERA as the gold standard was found to be 80%, which means that TEOAE will miss out 20% hearing impaired neonates when used as an independent screening tool. An ideal screening tool should be 100% sensitive, but in practice, this seldom occurs. In this study, we could not identify any factor that truly affected the sensitivity of TEOAE. However, we were able to identify two factors that falsely reduced the sensitivity of TEOAE by affecting the outcome of BERA, which in these situations did not behave as a gold standard test. These factors were prematurity 8 and congenital hyperbilirubinemia 9, 10,11 . These observations of our study made us question the status of BERA as 'gold standard' screening tool. Also, we were able to appreciate that TEOAE is directly dependent upon the cochlear outer hair cell integrity 12 so will not be able to detect hearing impairment arising from retrocochlear pathologies.
The specificity of TEOAE in this study was calculated to be 92.85% that means that 7.14 % of the neonates when screened by TEOAE will give false positive result. In the present study we were able to identify two factors that significantly reduced the specificity of TEOAE. First factor is blocked EAC and the second, collapsible EAC. No middle ear factor was found to be responsible. Similar observations were reported in various other studies 13, 14, 15, 16 . Thus, all TEOAE failures should be subjected to otoscopic evaluation. However, we feel that otoscopy preceding every TEOAE testing is rather unnecessary, as this will nullify the real advantages of TEOAE as screening tool -its rapidity and simplicity.
Time Factor : The time taken to complete TEOAE and BERA for every subject was recorded using a stopwatch. The time was
